ERBB2 and adenocarcinoma: In GAC, HER-2/neu, a member of the epidermal growth factor family and overexpressed or amplified in various other tumors including breast, colon and other adenocarcinomas, has been shown to be a useful marker for anti-HER-2 antibody therapy [11].